Related Experiment Video
Updated: Jul 23, 2025

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in
Pei-Chieh Tien1, Xiyue Chen1, Bennett D Elzey2,3
1Department of Animal Sciences, Purdue University, West Lafayette, IN, 47907, USA.
Abstract:
Human dedifferentiated liposarcoma (DDLPS) is a rare but lethal cancer with no driver mutations being identified, hampering the development of targeted therapies. We and others recently reported that constitutive activation of Notch signaling through overexpression of the Notch1 intracellular domain (NICDOE) in murine adipocytes leads to tumors resembling human DDLPS. However, the mechanisms underlying the oncogenic functions of Notch activation in DDLPS remains unclear. Here, we show that Notch signaling is activated in a subset of human DDLPS and correlates with poor prognosis and expression of MDM2, a defining marker of DDLPS. Metabolic analyses reveal that murine NICDOE DDLPS cells exhibit markedly reduced mitochondrial respiration and increased glycolysis, mimicking the Warburg effect. This metabolic switch is associated with diminished expression of peroxisome proliferator-activated receptor gamma coactivator 1α (Ppargc1a, encoding PGC-1α protein), a master regulator of mitochondrial biogenesis. Genetic ablation of the NICDOE cassette rescues the expression of PGC-1α and mitochondrial respiration. Similarly, overexpression of PGC-1α is sufficient to rescue mitochondria biogenesis, inhibit the growth and promote adipogenic differentiation of DDLPS cells. Together, these data demonstrate that Notch activation inhibits PGC-1α to suppress mitochondrial biogenesis and drive a metabolic switch in DDLPS.
Insights
Notch signaling activation in dedifferentiated liposarcoma (DDLPS) suppresses PGC-1α, inhibiting mitochondrial function and promoting cancer growth. Restoring PGC-1α reverses these effects, offering a potential therapeutic target for this lethal cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Dedifferentiated liposarcoma (DDLPS) is a rare, lethal cancer lacking identified driver mutations, hindering targeted therapy development.
- Constitutive Notch signaling activation, via Notch1 intracellular domain overexpression (NICDOE), in murine adipocytes models human DDLPS.
- The precise mechanisms of Notch activation's oncogenic role in DDLPS remain largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanisms by which Notch signaling drives DDLPS.
- To investigate the link between Notch activation, cellular metabolism, and prognosis in DDLPS.
- To identify potential therapeutic targets for DDLPS based on Notch signaling pathways.
Main Methods:
- Analysis of Notch signaling activation in human DDLPS patient samples.
- Metabolic profiling of murine NICDOE DDLPS cells using respirometry and glycolysis assays.
- Genetic manipulation to ablate NICDOE or overexpress PGC-1α in DDLPS cells.
- Assessment of mitochondrial biogenesis, cell growth, and adipogenic differentiation.
Main Results:
- Notch signaling is activated in a subset of human DDLPS, correlating with poor prognosis and MDM2 expression.
- Murine NICDOE DDLPS cells exhibit reduced mitochondrial respiration and increased glycolysis (Warburg effect).
- Notch activation diminishes peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α) expression, a key regulator of mitochondrial biogenesis.
- Genetic rescue of NICDOE or PGC-1α overexpression restored mitochondrial function, inhibited tumor growth, and promoted adipogenic differentiation.
Conclusions:
- Notch signaling activation in DDLPS suppresses PGC-1α, leading to impaired mitochondrial biogenesis and a metabolic shift towards glycolysis.
- Restoration of PGC-1α function can reverse the metabolic and proliferative phenotypes of DDLPS.
- Targeting the Notch-PGC-1α axis represents a promising therapeutic strategy for DDLPS.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...